Insider Buy Spurs Hope: Haoxi Health’s Reverse Split Raises Investor Confidence in a Low‑Price Stock
CEO insider buys 40 million Haoxi Health shares at a premium—could signal confidence, boost liquidity, yet risk remains high in a struggling biotech penny stock.
3 minutes to read